Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice.
Sign Up to like & getrecommendations! Published in 2018 at "Actas urologicas espanolas"
DOI: 10.1016/j.acuro.2017.10.003
Abstract: BACKGROUND The natural progression of bladder tumours (nonmuscle-invasive bladder cancer [NMIBC]) is recurrence with a high rate of progression. Bacille Calmette-Guérin (BCG) has been shown effective in reducing these rates, but there are few comparative… read more here.
Keywords: various strains; bladder; safety; bacille calmette ... See more keywords
Mycobacterium bovis infection of total hip arthroplasty after intravesicular Bacillus Calmette-Guérin
Sign Up to like & getrecommendations! Published in 2019 at "Arthroplasty Today"
DOI: 10.1016/j.artd.2019.08.004
Abstract: Intravesicular application of Bacillus Calmette-Guérin (BCG), a live attenuated strain of Mycobacterium bovis, is effective in the treatment of bladder cancer. However, systemic dissemination and subsequent infection of implants have been reported. We present a… read more here.
Keywords: bovis infection; mycobacterium bovis; infection; bovis ... See more keywords
Regression of the Sweet's syndrome after Bacillus Calmette-Guérin therapy: A bladder cancer case report
Sign Up to like & getrecommendations! Published in 2020 at "Urology Case Reports"
DOI: 10.1016/j.eucr.2020.101202
Abstract: The Sweet's syndrome is a rare dermatosis which can be related to underlying malignancies. In this case we presented a case, who applied to our clinic with severe dermatosis and hematuria. We diagnosed high grade… read more here.
Keywords: sweet syndrome; rin therapy; bladder; case ... See more keywords
Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2018.06.018
Abstract: Bacillus Calmette-Guérin (BCG) is used as first-line intravesical therapy following tumor resection of non-muscle-invasive bladder cancer. Primary producers of BCG announced shortages within the last decade, leading to a worldwide shortage. We review the literature… read more here.
Keywords: bacillus calmette; shortage; manufacturing market; calmette rin ... See more keywords
Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle invasive Bladder Cancer: Con.
Sign Up to like & getrecommendations! Published in 2021 at "European urology focus"
DOI: 10.1016/j.euf.2021.09.005
Abstract: The use of sequential intravesical instillation of gemcitabine and docetaxel in the management of bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer should not be recommended as a second-line treatment. First, technical issues are a barrier to broad… read more here.
Keywords: rin unresponsive; muscle invasive; unresponsive non; non muscle ... See more keywords
Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
Sign Up to like & getrecommendations! Published in 2020 at "European Urology"
DOI: 10.1016/j.eururo.2020.08.027
Abstract: Take Home Message Our understanding of the mechanism of bacillus Calmette-Guérin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor… read more here.
Keywords: bacillus calmette; mechanism; calmette rin;
Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"
DOI: 10.1016/j.jctube.2020.100152
Abstract: Vascular bypass graft infection with Mycobacterium bovis following Bacillus Calmette–Guérin (BCG) immunotherapy for bladder cancer is an incredibly rare complication. We present the case of an 85-year-old man with a history of femorofemoral bypass who… read more here.
Keywords: bypass; mycobacterium bovis; graft; bacillus calmette ... See more keywords
Can immunization with Bacillus Calmette-Guérin (BCG) protect against Alzheimer's disease?
Sign Up to like & getrecommendations! Published in 2019 at "Medical hypotheses"
DOI: 10.1016/j.mehy.2019.01.007
Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder which is the most prevalent cause of dementia in the western world. Currently, it is the most expensive disease in America, costing more than heart diseases and cancer… read more here.
Keywords: disease; bacillus calmette; calmette rin; bcg ... See more keywords
Microscopic detection of bacillus Calmette–Guérin mycobacteria in bladder biopsy using fluorescence in situ hybridization
Sign Up to like & getrecommendations! Published in 2021 at "New Microbes and New Infections"
DOI: 10.1016/j.nmni.2020.100826
Abstract: Intravesical instillation of Bacilli Calmette Guérin (BCG) as a superficial bladder cancer treatment is generally well tolerated, but local or systemic complications may occur, some of which may be life-threatening. Following the suspicion of post-BCG… read more here.
Keywords: fluorescence situ; bladder; calmette rin; situ hybridization ... See more keywords
Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation
Sign Up to like & getrecommendations! Published in 2020 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.11.060
Abstract: Background: Bacille Calmette-Guérin (BCG), the live attenuated tuberculosis vaccine, is manufactured under different conditions across the globe generating formulations that may differ in clinical efficacy. Innate immune recognition of live BCG contributes to immunogenicity suggesting… read more here.
Keywords: innate; viability; rna content; bacille calmette ... See more keywords
Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial.
Sign Up to like & getrecommendations! Published in 2020 at "Vaccine"
DOI: 10.1016/j.vaccine.2020.02.006
Abstract: BACKGROUND The Bacille Calmette-Guérin (BCG) vaccine against tuberculosis (TB) may have beneficial non-specific effects (NSEs) beyond the protection against TB. This may be related to modifications of the innate immune system. We investigated the effect… read more here.
Keywords: birth differential; bacille calmette; blood; calmette rin ... See more keywords